Medical News Diabetes Cell MedX Corp. (OTCQB: CMXC) therapeutic products for patients with diabetes like eBalance
New York, NY – Since Friday’s profile of Cell MedX Corp. (OTCQB: CMXC) therapeutic products for patients with diabetes the corporate video which was at 2,334 views has received over 5,000 total views of its YouTube video at https://youtu.be/dC_UnMcPiis
TheOTCReports.com tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting TheOTCReports.com
Today’s alerts include: Cell MedX Corp. (OTCQB: CMXC) $.28
TheOTCReports.com strives to bring our knowledge of the marketplace and explosive growth opportunities directly to our qualified subscribers. By exploring companies that have yet to receive any major market exposure, our clients can position themselves before a market upsurge occurs allowing for a profitable entry into an equity.
Our strength lies in finding these undervalued and under-marketed companies and delivering our research to our clients. Today we have initiated a profile on Cell MedX Corp. which is available at http://theotcreports.com/profile-cmxc.htm which recently announced it introduced Ongoing eBalance Pro Trial Observations Online.
About Cell MedX Corp. (OTCQB: CMXC)
Cell MedX Corp. is a development stage company focused on the commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications
Recent News: http://goo.gl/8OWY73
Cell MedX Corp.
For further information visit: www.cellmedx.com
Or phone: 1-844-238-2692
KeyWords: Diabetes Study, Diabetes, Type 1 diabetes, Type 2 diabetes, Diabetes Symptoms, Insulin, Diabetes Symptoms, Diabetes Causes, Diabetes Treatments, International Diabetic Federation, American Diabetes Association, Canadian Diabetes Association.ADA, CDA, IDF